Cancer BiologybioRxivPreprint
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy
Rishita Chatterjee, Arturo Simoni Nieves, An Nhien Truong…·Yosef Yarden
This study identifies a p53 mutation-specific immunotherapy strategy for ovarian cancer by targeting AREG and PD-L1, showing efficacy in mouse models and patient-derived organoids.